The Boston-Haifa Life Sciences Initiative (BHLSI) Business-to-Business (B2B) Working Group

The Boston-Haifa Life Sciences Initiative (BHLSI) has assembled a voluntary B2B team of sophisticated life science experts, both in Massachusetts and in Israel. A partial list of participants in the BHLSI B2B network is included below.

Massachusetts

Dalia Cohen , Novartis Institutes for BioMedical Research
Hillel Bachrach , 20/20 HealthCare Partners LLC
David Barone , Boston MedTech Advisors, Inc.
Darren Black , SV Life Sciences
Yael Biran , Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C
Steve Doppelt , Medical Products Consultant
Jonathan Fleming , Oxford BioScience Partners
Iriving Fox , Millennium Pharmaceuticals
Michael Greeley , IDG Ventures
Richard Brudnick , BiogenIdec
Henry Kay , The Kierestu Forum
Yigal Koltin , Strategy Advisor
Mordecai Kramer , Harvard Clinical Research Institute
Don Perrin , Cambridge Business Advisors
Mel Prenovitz , The Incus Group
Marc Rubenstein , Ropes & Gray
Martin Sklar , AlvaMed, LLC
Jerry Shaufeld , Consultant
Steve Targum , Consultant

Israel

Peninna Safer , PhD, Partner, Medica
Gideon Sturlesi , Founder and General Partner, BioMedical Israel
Ben Soffer , Director, Technion Research & Development Foundation
Ken Shostack , Business Advisor, ASAP
Uri Attir , US-Israel Bi-National Industrial R&D (BIRD) Foundation BIRD
Steve Rhodes , Misgav Technology Center
Ishay Attar , Misgav Technology Center
Elisha Yelin , Meytag Incubator
Nir Levi, CEO, Visionpoint